Earnings Call · Q2 FY2025·2025-08-07

Q2 25EPS -29.41%·Rev n/aQ1 25EPS +3.45%·Rev n/aQ4 24EPS -2.18%·Rev n/aQ3 24EPS +60.00%·Rev n/a⚠ consensus missing

Skye Bioscience, Inc. SKYE

Unidentified Company Representative

Punit S. Dhillon — Chief Executive Officer

Kaitlyn Melanie Arsenault — Finance/Financial Officer

−0.8%1d on move date−1.6% vs SPY3d−8.5%5d−7.9%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more SKYE calls or request research access.

More SKYE calls Browse calls Request research access